ArticleJournal of oral and maxillofacial pathology : JOMFP
Comparative evaluation of Fascin-1 with clinicopathological parameters and recurrence in oral squamous cell carcinoma.
Article in Journal of oral and maxillofacial pathology : JOMFP. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Squamous cell carcinoma is the most common epithelial malignancy of the oral cavity. The 5-year survival rate is approximately 50% and is even lower, that is, 30% in the patients with recurrence of this disease. Because recurrence has a major influence on 5-year survival, it becomes imperative to identify the molecular elements responsible for the recurrence of oral squamous cell carcinoma. Aim: To evaluate the expression of fascin-1 and its correlation with clinicopathological parameters and recurrence in the patients of oral squamous cell carcinoma. Materials and Methods: A cohort study was conducted in the Department of Oral Pathology, SPDC, Wardha. A 4 μm thick section from paraffin-embedded blocks of formalin-fixed biopsy tissues of 60 cases having primary oral squamous cell carcinoma was processed and stained with mouse monoclonal fascin-1 (Clone: SPM133) antibodies. Results: In the present study, all cases which had a final score above 2, denotes a strong positive immunostaining of fascin in OSCC. Tumour size was significantly correlated with fascin expression, whereas no significant association was found for other parameters, such as age, gender, node involvement, and grade of the tumour and recurrence. Conclusion: Fascin was found to be significantly correlated with tumour size. Fascin expression was found to be related with recurrence but no significant association exists. As recurrence is directly related to the poor prognosis and survival rate; so, it is essential to identify molecular markers indicative of recurrence. Fascin can be used to identify a subset of oral squamous cell carcinoma patients that are prone to recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.